The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide, which Novo markets as Ozempic and Wegovy.

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

Raleigh Weight Loss Center warns of GLP-1 medication risks & offers safe, natural weight loss solutions focusing on ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including osteoporosis and gout.

The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that ...

GLP-1 users are buying chocolate at a higher rate than the rest of the U.S., according to Swiss chocolatier Lindt & Sprüngli. The chocolate maker released data that shows the surge in weight-loss ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

Post-diagnosis weight gain over ~1.5 years is consistently associated with increased breast cancer–specific and all-cause mortality across meta-analyses. How GLP-1 weight-loss drugs fit after breast ...

Every bite matters when you start taking a GLP-1. Prioritizing nutrient-dense foods that support your gut and digestive health and maintaining proper hydration can make a real difference in your ...

The FDA issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster medications.